Literature DB >> 15748949

A paradoxical role of APCs in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.

Guang-Xian Zhang1, Shuo Yu, Yonghai Li, Elvira S Ventura, Bruno Gran, Abdolmohamad Rostami.   

Abstract

The central role of T cells in the induction of tolerance to autoantigens has been well documented. However, the role of antigen-presenting cells (APCs) in this process is not yet fully understood. To better understand the contribution of APCs in tolerance, we studied the interaction of purified APCs and CD4(+) T cells in a model of intravenous (i.v.) tolerance to experimental autoimmune encephalomyelitis (EAE). As expected, we found that T cells were tolerized to the autoantigen after i.v. injection. However, purified APCs obtained from MOG-i.v.-treated mice were paradoxically immuno-stimulatory, as they induced a non-specific Th1-type response both in vitro and in vivo. We conclude that blocking such APC activation would enhance the effectiveness of tolerance induction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748949     DOI: 10.1016/j.jneuroim.2004.12.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

2.  Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.

Authors:  Junda Kel; Judith Oldenampsen; Mariken Luca; Jan Wouter Drijfhout; Frits Koning; Lex Nagelkerken
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balance.

Authors:  Zhao Zhao; Bogoljub Ciric; Shuo Yu; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Int Immunol       Date:  2010-08-02       Impact factor: 4.823

4.  Intravenous tolerance effectively overcomes enhanced pro-inflammatory responses and experimental autoimmune encephalomyelitis severity in the absence of IL-12 receptor signaling.

Authors:  Denise C Fitzgerald; Guang-Xian Zhang; Shuo Yu; Melissa L Cullimore; Zhao Zhao; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-04-21       Impact factor: 3.478

5.  Intravenous tolerance modulates macrophage classical activation and antigen presentation in experimental autoimmune encephalomyelitis.

Authors:  Hongmei Li; Bogoljub Ciric; Jingxian Yang; Hui Xu; Denise C Fitzgerald; Mohamed Elbehi; Zoe Fonseca-Kelly; Shuo Yu; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2009-02-01       Impact factor: 3.478

Review 6.  Emerging immunopharmacological targets in multiple sclerosis.

Authors:  Mojtaba Farjam; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  J Neurol Sci       Date:  2015-09-14       Impact factor: 3.181

7.  Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial.

Authors:  Fereshteh Ashtari; Mohammad Reza Savoj
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

8.  Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.

Authors:  Vahid Shaygannejad; Mohsen Janghorbani; Fereshteh Ashtari; Hamed Dehghan
Journal:  Mult Scler Int       Date:  2012-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.